Small business innovative research phase i, proposal H252-001-0018, titled: integrated multiplexed low-cost diagnostic platform for rapid microbial identification, medical research and development…
Ended Purchase Order Awarded Last action
- Contract number
- HT942525PE012
- Awardee
-
Emergingdx Inc. UEI C1LMYC2AY934
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $249,969
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $249,969.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 24 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lowell, MA 01852, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency has awarded a $249,969 Small Business Innovation Research (SBIR) Phase I contract to Emergingdx Inc., a Lowell, Massachusetts-based diagnostic technology company, for the development of an integrated multiplexed low-cost diagnostic platform for rapid microbial identification. This total small business set-aside contract, designated as a purchase order with firm fixed price terms, represents the initial phase of research and development aimed at advancing medical diagnostic capabilities. The contract runs through March 21, 2026, with performance conducted at the company's Lowell facility.
Emergingdx Inc. brings significant expertise in biosensor and diagnostic platform development to this engagement, building on its track record of securing multiple SBIR and Small Business Technology Transfer contracts from the Defense Health Agency and Office of Naval Research. The company specializes in multiplexed diagnostic technologies and pathogen identification systems with applications spanning military and civilian healthcare environments. This Phase I award positions the contractor to advance its innovative diagnostic approach, with potential for continuation into subsequent development phases that could expand the platform's capabilities and market applications within the federal healthcare and defense sectors.
Description
Small business innovative research phase i, proposal H252-001-0018, titled: integrated multiplexed low-cost diagnostic platform for rapid microbial identification, medical research and development contract.
Quick answers
Who was awarded contract HT942525PE012?
HT942525PE012 was awarded to Emergingdx Inc. by Defense Health Agency (Department of Defense) on August 22, 2025.
How much is contract HT942525PE012 worth?
The government has obligated $249,969 on HT942525PE012.
Was contract HT942525PE012 competed?
The extent of competition for HT942525PE012 was full and open competition after exclusion of sources. The government received 24 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award